Actualités iId
Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP
Wed, 04 Dec 2024 16:00:00 GMT
LONDON, England—Two-year results from the CLASP IID randomized trial and registry confirm the early benefits of transcatheter edge-to-edge repair (TEER) with the Pascal system (Edwards Lifesciences) ...